A Marine-Derived Streptomyces Sp. MS449 Produces High Yield of Actinomycin X 2 and Actinomycin D with Potent Anti-Tuberculosis Activity

Caixia Chen,Fuhang Song,Qian Wang,Wael M. Abdel-Mageed,Hui Guo,Chengzhang Fu,Weiyuan Hou,Huanqin Dai,Xueting Liu,Na Yang,Feng Xie,Ke Yu,Ruxian Chen,Lixin Zhang
DOI: https://doi.org/10.1007/s00253-012-4079-z
IF: 5
2012-01-01
Applied Microbiology and Biotechnology
Abstract:In the course of our screening program for anti-Mycobacterium bovis bacillus Calmette-Guérin (BCG) and anti-Mycobacterium tuberculosis H37Rv (MTB H37Rv) agents from our marine natural product library, a newly isolated actinomycete strain, designated as MS449, was picked out for further investigation. The strain MS449, isolated from a sediment sample collected from South China Sea, produced actinomycin X2 and actinomycin D in substantial quantities, which showed strong inhibition of BCG and MTB H37Rv. The structures of actinomycins were elucidated by nuclear magnetic resonance and mass spectrometric analysis. The strain MS449 was taxonomically characterized on the basis of morphological and phenotypic characteristics, genotypic data, and phylogenetic analysis. The 16S rRNA gene sequence of the strain was determined and a database search indicated that the strain was closely associated with the type strain of Streptomyces avermitilis (99.7 % 16S rRNA gene similarity). S. avermitilis has not been previously reported to produce actinomycins. The marine-derived strain of Streptomyces sp. MS449 produced notably higher quantities of actinomycin X2 (1.92 mg/ml) and actinomycin D (1.77 mg/ml) than previously reported actinomycins producing strains. Thus, MS449 was considered of great potential as a new industrial producing strain of actinomycin X2 and actinomycin D.
What problem does this paper attempt to address?